Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00447837
Status:
COMPLETED
Last Update Posted:
2008-03-17
First Post:
2007-03-13
Brief Title:
Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis
Sponsor:
Naryx Pharma
Organization:
Naryx Pharma
Study Overview
Official Title:
A Phase 2 Double-Blind Placebo-Controlled Multi-Center Randomized Study Evaluating the Safety and Efficacy of SPRC-AB01 Tobramycin Solution for Nasal Inhalation in Post-Surgical Subjects With Chronic Sinusitis
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of the study is to evaluate the safety and efficacy of SPRC-AB01 versus placebo for treatment of chronic sinusitis in subjects who have had sinus surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None